← Back to Clinical Trials
Recruiting NCT06193057

NCT06193057 Comparison of Customized and Standard Total Ankle Prostheses

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06193057
Status Recruiting
Phase —
Sponsor Istituto Ortopedico Rizzoli
Condition Ankle Osteoarthritis
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2023-07-26
Primary Completion 2026-04-30

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Total ankle arthroplasty

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2023-07-26 with a primary completion date of 2026-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objective of this study is to compare primary total ankle replacement (TAR) performed with a customized procedure (prostheses customized for each patient based on his or her ankle morphology reconstructed from tomographic scans, and implanted via cutting guides customized for the patient) with standard primary TARs, considering: objective radiological results, subjective patient outcomes, and overall costs of both procedures

Eligibility Criteria

Inclusion Criteria: * Male and female subjects older than 40 years and younger than 75 years (≥ 40 age ≤ 75 years) with arthrosis at the unilateral tibio-tarsal joint who are candidates for primary total ankle replacement. * Consenting patients and able to complete scheduled study procedures and follow-up evaluations. * Patients who have signed the "informed consent" approved by the Ethics Committee. Exclusion Criteria: * Social conditions (homeless patients, with restrictions on personal freedom) * ASA 3 and 4 * Deep venous insufficiency Lower limbs * History of Erisipelas lower limbs * Neurological or psychocognitive disorders * neurological diseases * Axial deformities of ankle \>15° * Personal or family history of DVT or EP * Prosthetic and/or arthrodesis surgeries at another lower extremity joint except that candidate for ankle prosthesis) * Pregnant women * Patients with rheumatic diseases * Patients that requires ancillary surgical procedures

Contact & Investigator

Central Contact

massimiliano mosca, MD

✉ massimiliano.mosca@ior.it

📞 0516366

Frequently Asked Questions

Who can join the NCT06193057 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 75 Years, studying Ankle Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06193057 currently recruiting?

Yes, NCT06193057 is actively recruiting participants. Contact the research team at massimiliano.mosca@ior.it for enrollment information.

Where is the NCT06193057 trial being conducted?

This trial is being conducted at Bologna, Italy.

Who is sponsoring the NCT06193057 clinical trial?

NCT06193057 is sponsored by Istituto Ortopedico Rizzoli. The trial plans to enroll 24 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology